Viewing Study NCT01987492


Ignite Creation Date: 2025-12-24 @ 3:19 PM
Ignite Modification Date: 2026-04-17 @ 12:23 AM
Study NCT ID: NCT01987492
Status: COMPLETED
Last Update Posted: 2017-05-22
First Post: 2013-11-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent Asthma
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module